Thursday, April 10, 2025

Potential Alzheimer's disease therapeutic target identified in brain immune cells

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. Researchers used preclinical models to uncover Tim-3's role in microglia, the brain's resident immune cells, and have identified it as a promising therapeutic target for Alzheimer's disease.

from Top Health News -- ScienceDaily https://ift.tt/tinrzlG

No comments:

Post a Comment

Ozempic changed obesity treatment, but experts say the real revolution is next

The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now env...